Wang, Zhuyin, Ph.D.

Co-founder & Chief Scientific Officer

  • Professor of Lanzhou University, Hehai University
  • Former CEO of Nanjing Kinome, China
  • Former Vice President of GenScript, China and Director of GenScipt, USA
  • Former Senior Scientist, PharmaSeq, Inc., USA
  • Ph.D. in Biochemistry and Molecular Biology, The State University of New Jersey, USA
  • Postdoctoral Fellow, Columbia University, USA
  • About 30 years of experience in peptide and nucleic acid synthetic chemistry, biosynthesis of peptide, peptide drug design and peptide reagent production.
  • Inventor of 40+ patents related to peptides

Li, Sean (Xiangqun), Ph.D.

Co-founder & Chief Executive Officer

  • Former Vice President, Chengdu Shengnuo Biopharmaceutical Co., Ltd., China
  • Former Executive Director, WuxiApptec, China
  • Former Director, GenScript, China
  • Postdoctoral Fellow, University of Maryland, Purdue University, USA
  • Postdoctoral Fellow, University of Osaka, Japan
  • Ph.D. in Chemistry, Peking University
  • More than 25 years of experience in peptide synthetic chemistry and biology, peptide drug and reagent research and production

Cheng, Lei, B.S.

Co-founder & President

  • Former Executive Vice President, Hunan Jinsha Pharmaceuticals, China
  • Executive Director, Anson Biotech, China
  • Member of the Board of Directors in several pharmaceutical companies
  • Over 20 years of experience in investment, business development, marketing and commercial transformation deals

Gong, Huanzhang, B.S.

Co-founder and Vice president

  • Former General Manager, Hunan Jinsha Drug Distribution Co., China
  • Investor partner of several pharmaceutical companies
  • Over 30 years of experience in marketing, sales and investment in pharmaceutical industry

Liu, Henry Huiqing, M.D.

Vice President

  • Former Vice President, PharmaCore Labs, China
  • Former Senior Director and Research Fellow, Shanghai Chempartner Co. Ltd., China
  • Former Research Scientist/Senior Research Scientist in Neuromed Pharmaceuticals, Canada and Icagen, Inc., USA
  • M.D. from Peking University, China
  • M.S. in Molecular Biology from University of North Texas and M.S. in Computer Sciences from University of Texas
  • More than 25 years of experience in drug screening, bioassays, pharmacology assays, preclinical cardiac safety evaluation, ion channel drugs from early discovery to clinical stages

Sally Wang Liang, Esq., J,D., M.P.H.

VP of Business Development

  • Biopharma & healthcare business executive and IP & Regulatory lawyer with 15+ years of healthcare industry experience
  • Former FDA Office of Policy and US Senate Health Office
  • Former CEO, DocFlight, and CSO, of Click Therapeutics
  • Consultant to Pfizer, Sanofi, Novartis, Roche-Genetech, etc.
  • J.D. from Harvard Law School, M.P.H from Harvard T.H. Chan School of Public Health, A.B. in Biology with high honors from Harvard College